Table 1 Clinical characteristics in the metabolic associated molecular subtypes in The Cancer Genome Atlas cohort
From: Characterization of metabolism-associated molecular patterns in prostate cancer
Variables | Cluster1 (N = 264) | Cluster2 (N = 225) | P-value |
|---|---|---|---|
Age | |||
 < 60 | 96 (36.4%) | 103 (45.8%) | 0.0434 |
 ≥ 60 | 168 (63.6%) | 122 (54.2%) |  |
Pathologic T | |||
 T2 | 81 (30.7%) | 104 (46.2%) |  < 0.001 |
 T3 | 177 (67.0%) | 111 (49.3%) |  |
 T4 | 5 (1.9%) | 5 (2.2%) |  |
 NA | 1 (0.4%) | 5 (2.2%) |  |
Pathologic N | |||
 N0 | 176 (66.7%) | 164 (72.9%) | 0.0013 |
 N1 | 56 (21.2%) | 21 (9.3%) |  |
 NA | 32 (12.1%) | 40 (17.8%) |  |
PSA value | |||
 < 4 | 208 (78.8%) | 198 (88.0%) | 0.231 |
 ≥ 4 | 17 (6.4%) | 9 (4.0%) |  |
 NA | 39 (14.8%) | 18 (8.0%) |  |
Gleason score | |||
 < 8 | 129 (48.9%) | 160 (71.1%) |  < 0.001 |
 ≥ 8 | 135 (51.1%) | 65 (28.9%) |  |